EpCAM proteolysis: New fragments with distinct functions?

Bioscience Reports

Volumn 33, Issue 2, 2013, Pages 321-332

  Schnell, Ulrike ^a   Kuipers, Jeroen ^a   Giepmans, Ben N G ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Cell cell contact; EpCAM; Notch like signalling; Polypeptides; Regulated intramembrane proteolysis; Shedding

Indexed keywords

EPITHELIAL CELL ADHESION MOLECULE; PROTEIN ANTIBODY; SIGNAL PEPTIDE; ANTIIDIOTYPIC ANTIBODY; CELL ADHESION MOLECULE; EPCAM PROTEIN, HUMAN; TUMOR ANTIGEN;

ARTICLE; CELL PROLIFERATION; CULTURE MEDIUM; DOWN REGULATION; HUMAN; HUMAN CELL; INTRACELLULAR SIGNALING; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN CLEAVAGE; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN FUNCTION; CELL COMMUNICATION; CHEMISTRY; GENETICS; HCT116 CELL LINE; HEK293 CELL LINE; METABOLISM; NEOPLASM; PROTEIN TERTIARY STRUCTURE; SIGNAL TRANSDUCTION;

ANTIBODIES, ANTI-IDIOTYPIC; ANTIGENS, NEOPLASM; CELL ADHESION MOLECULES; CELL COMMUNICATION; CELL PROLIFERATION; HCT116 CELLS; HEK293 CELLS; HUMANS; NEOPLASMS; PROTEIN STRUCTURE, TERTIARY; PROTEOLYSIS; SIGNAL TRANSDUCTION;

EID: 84877779621     PISSN: 01448463     EISSN: 15734935     Source Type: Journal    
DOI: 10.1042/BSR20120128     Document Type: Article

References (53)

1. Cirulli, V., Crisa, L., Beattie, G. M., Mally, M. I., Lopez, A. D., Fannon, A., Ptasznik, A., Inverardi, L., Ricordi, C., Deerinck, T. et al. (1998) KSA antigen Ep-CAM mediates cell-cell adhesion of pancreatic epithelial cells: morphoregulatory roles in pancreatic islet development. J. Cell Biol. 140, 1519-1534 (Pubitemid 28152999)
2. Trzpis, M., McLaughlin, P. M. J., de Leij, L. M. F. H. and Harmsen, M. C. (2007) Epithelial cell adhesion molecule: more than a carcinoma marker and adhesion molecule. Am. J. Pathol. 171, 386-395 (Pubitemid 47344671)
3. de Boer, C. J., van Krieken, J. H., Janssen-van Rhijn, C. M. and Litvinov, S. V. (1999) Expression of Ep-CAM in normal, regenerating, metaplastic, and neoplastic liver. J. Pathol. 188, 201-206
4. Sundberg, M., Jansson, L., Ketolainen, J., Pihlajamäki, H., Suuronen, R., Skottman, H., Inzunza, J., Hovatta, O. and Narkilahti, S. (2009) CD marker expression profiles of human embryonic stem cells and their neural derivatives, determined using flow-cytometric analysis, reveal a novel CD marker for exclusion of pluripotent stem cells. Stem Cell Res. 2, 113-124
5. Baeuerle, P. A. and Gires, O. (2007) EpCAM (CD326) finding its role in cancer. Br. J. Cancer 96, 417-423 (Pubitemid 46215211)
6. van der Gun, B. T. F., Melchers, L. J., Ruiters, M. H. J., de Leij, L. F. M. H., McLaughlin, P. M. J. and Rots, M. G. (2010) EpCAM in carcinogenesis: the good, the bad or the ugly. Carcinogenesis 31, 1913-1921
7. Patriarca, C., Macchi, R. M., Marschner, A. K. and Mellstedt, H. (2012) Epithelial cell adhesion molecule expression (CD326) in cancer: a short review. Cancer Treat. Rev. 38, 68-75
8. Sivagnanam, M., Mueller, J. L., Lee, H., Chen, Z., Nelson, S. F., Turner, D., Zlotkin, S. H., Pencharz, P. B., Ngan, B.-Y., Libiger, O. et al. (2008) Identification of EpCAM as the gene for congenital tufting enteropathy. Gastroenterology 135, 429-437
9. Strnad, J., Hamilton, A. E., Beavers, L. S., Gamboa, G. C., Apelgren, L. D., Taber, L. D., Sportsman, J. R., Bumol, T. F., Sharp, J. D. and Gadski, R. A. (1989) Molecular cloning and characterization of a human adenocarcinoma/ epithelial cell surface antigen complementary DNA. Cancer Res. 314-317 (Pubitemid 19049519)
10. Szala, S., Froehlich, M., Scollon, M., Kasai, Y., Steplewski, Z., Koprowski, H. and Linnenbach, A. J. (1990) Molecular cloning of cDNA for the carcinoma-associated antigen GA733-2. Proc. Natl. Acad. Sci. U.S.A. 87, 3542-3546
11. Chong, J. M. and Speicher, D. W. (2001) Determination of disulfide bond assignments and N-glycosylation sites of the human gastrointestinal carcinoma antigen GA733-2 (CO17-1A, EGP, KS1-4, KSA, and Ep-CAM). J. Biol. Chem. 276, 5804-5813
12. Thampoe, I. and Ng, J. (1988) Biochemical analysis of a human epithelial surface antigen: differential cell expression and processing. Arch. Biochem. Biophys. 267, 342-352 (Pubitemid 19001035)
13. Schön, M. P., Schön, M., Mattes, M. J., Stein, R., Weber, L., Alberti, S. and Klein, C. E. (1993) Biochemical and immunological characterization of the human carcinoma-associated antigen MH 99/KS 1/4. Int. J. Cancer 55, 988-995 (Pubitemid 24005346)
14. Maetzel, D., Denzel, S., Mack, B., Canis, M., Went, P., Benk, M., Kieu, C., Papior, P., Baeuerle, P. A., Münz, M. et al. (2009) Nuclear signalling by tumour-associated antigen EpCAM. Nat. Cell Biol. 11, 162-171
15. Brown, M. S., Ye, J., Rawson, R. B. and Goldstein, J. L. (2000) Regulated intramembrane proteolysis: a control mechanism conserved from bacteria to humans. Cell 100, 391-398
16. Lichtenthaler, S. F., Haass, C. and Steiner, H. (2011) Regulated intramembrane proteolysis-lessons from amyloid precursor protein processing. J. Neurochem. 117, 779-796
17. Arribas, J. and Borroto, A. (2002) Protein ectodomain shedding. Chem. Rev. 102, 4627-4638
18. van Kilsdonk, J. W. J., van Kempen, L. C. L. T., van Muijen, G. N. P., Ruiter, D. J. and Swart, G. W. M. (2010) Soluble adhesion molecules in human cancers: sources and fates. Eur. J. Cell Biol. 89, 415-427
19. Winter, M. J., Cirulli, V., Briaire-de Bruijn, I. H. and Litvinov, S. V. (2007) Cadherins are regulated by Ep-CAM via phosphaditylinositol-3 kinase. Mol. Cell. Biochem. 302, 19-26 (Pubitemid 47202316)
20. Schnell, U., Kuipers, J., Mueller, J. L., Veenstra-Algra, A., Sivagnanam, M. and Giepmans, B. N. G. (2013) Absence of cell surface EpCAM in congenital tufting enteropathy. Hum. Mol. Genet., doi: 10.1093/hmg/ddt105
21. Hageman, J., Vos, M. J., van Waarde, M. A and Kampinga, H. H. (2007) Comparison of intra-organellar chaperone capacity for dealing with stress-induced protein unfolding. J. Biol. Chem. 282, 34334-34345 (Pubitemid 350159444)
22. De Leij, L., Helfrich, W., Stein, R. and Mattes, M. J. (1994) SCLC-cluster-2 antibodies detect the pancarcinoma/epithelial glycoprotein EGP-2. Int. J. Cancer 8, 60-63 (Pubitemid 24188960)
23. Balzar, M., Winter, M. J., de Boer, C. J. and Litvinov, S. V. (1999) The biology of the 17-1A antigen (Ep-CAM). J. Mol. Med. 77, 699-712
24. Tuteja, R. (2005) Type I signal peptidase: an overview. Arch. Biochem. Biophys. 441, 107-111
25. Runz, S., Keller, S., Rupp, C., Stoeck, A., Issa, Y., Koensgen, D., Mustea, A., Sehouli, J., Kristiansen, G. and Altevogt, P. (2007) Malignant ascites-derived exosomes of ovarian carcinoma patients contain CD24 and EpCAM. Gynecol. Oncol. 107, 563-571 (Pubitemid 350160873)
26. Denzel, S., Maetzel, D., Mack, B., Eggert, C., Bärr, G. and Gires, O. (2009) Initial activation of EpCAM cleavage via cell-to-cell contact. BMC Cancer 9, 402
27. Neurath, H. and Walsh, K. A. (1976) Role of proteolytic enzymes in biological regulation (a review). Proc. Natl. Acad. Sci. U.S.A. 73, 3825-3832
28. Turk, V., Stoka, V., Vasiljeva, O., Renko, M., Sun, T., Turk, B. and Turk, D. (2012) Cysteine cathepsins: from structure, function and regulation to new frontiers. Biochim. Biophys. Acta 1824, 68-88
29. Mihelic, M. and Turk, D. (2007) Two decades of thyroglobulin type-1 domain research. Biol. Chem. 388, 1123-1130 (Pubitemid 350059629)
30. Nomura, T. and Katunuma, N. (2005) Involvement of cathepsins in the invasion, metastasis and proliferation of cancer cells. J. Med. Invest. 52, 1-9
31. Beel, A. J. and Sanders, C. R. (2008) Substrate specificity of gamma-secretase and other intramembrane proteases. Cell. Mol. Life Sci. 65, 1311-1334
32. Abe, H., Kuroki, M., Imakiire, T., Yamauchi, Y., Yamada, H., Arakawa, F. and Kuroki, M. (2002) Preparation of recombinant MK-1/Ep-CAM and establishment of an ELISA system for determining soluble MK-1/Ep-CAM levels in sera of cancer patients. J. Immunol. Methods 270, 227-233
33. Kimura, H., Kato, H., Faried, A., Sohda, M., Nakajima, M., Fukai, Y., Miyazaki, T., Masuda, N., Fukuchi, M. and Kuwano, H. (2007) Prognostic significance of EpCAM expression in human esophageal cancer. Int. J. Oncol. 30, 171-179
34. Petsch, S., Gires, O., Rüttinger, D., Denzel, S., Lippold, S., Baeuerle, P. A. and Wolf, A. (2011) Concentrations of EpCAM ectodomain as found in sera of cancer patients do not significantly impact redirected lysis and T-cell activation by EpCAM/CD3-bispecific BiTE antibody MT110. MAbs 3, 31-37
35. Ralhan, R., Cao, J., Lim, T., Macmillan, C., Freeman, J. L. and Walfish, P. G. (2010) EpCAM nuclear localization identifies aggressive thyroid cancer and is a marker for poor prognosis. BMC Cancer 10, 331
36. Ralhan, R., He, H. C.-H., So, A. K.-C., Tripathi, S. C., Kumar, M., Hasan, M. R., Kaur, J., Kashat, L., MacMillan, C., Chauhan, S. S. et al. (2010) Nuclear and cytoplasmic accumulation of Ep-ICD is frequently detected in human epithelial cancers. PloS ONE 5, e14130
37. Schnell, U., Dijk, F., Sjollema, K. A. and Giepmans, B. N. G. (2012) Immunolabeling artifacts and the need for live-cell imaging. Nat. Methods 9, 152-158
38. Edwards, D. R., Handsley, M. M. and Pennington, C. J. (2008) The ADAM metalloproteinases. Mol. Aspects Med. 29, 258-289
39. Craig, S. E. L. and Brady-Kalnay, S. M. (2011) Cancer cells cut homophilic cell adhesion molecules and run. Cancer Res. 71, 303-309
40. Kuhn, P.-H., Wang, H., Dislich, B., Colombo, A., Zeitschel, U., Ellwart, J. W., Kremmer, E., Rossner, S. and Lichtenthaler, S. F. (2010) ADAM10 is the physiologically relevant, constitutive alpha-secretase of the amyloid precursor protein in primary neurons. EMBO J. 29, 3020-3032
41. Cordy, J. M., Hussain, I., Dingwall, C., Hooper, N. M. and Turner, A. J. (2003) Exclusively targeting beta-secretase to lipid rafts by GPI-anchor addition up-regulates beta-site processing of the amyloid precursor protein. Proc. Natl. Acad. Sci. U.S.A. 100, 11735-11740 (Pubitemid 37206004)
42. Harris, B., Pereira, I. and Parkin, E. (2009) Targeting ADAM10 to lipid rafts in neuroblastoma SH-SY5Y cells impairs amyloidogenic processing of the amyloid precursor protein. Brain Res. 1296, 203-215
43. Ehehalt, R., Keller, P., Haass, C., Thiele, C. and Simons, K. (2003) Amyloidogenic processing of the Alzheimer beta-amyloid precursor protein depends on lipid rafts. J. Cell Biol. 160, 113-123 (Pubitemid 36091721)
44. Le Naour, F., André, M., Greco, C., Billard, M., Sordat, B., Emile, J.-F., Lanza, F., Boucheix, C. and Rubinstein, E. (2006) Profiling of the tetraspanin web of human colon cancer cells. Mol. Cell. Proteomics 5, 845-857 (Pubitemid 43792794)
45. Le Naour, F., André, M., Boucheix, C. and Rubinstein, E. (2006) Membrane microdomains and proteomics: lessons from tetraspanin microdomains and comparison with lipid rafts. Proteomics 6, 6447-6454 (Pubitemid 46048385)
46. Xu, D., Sharma, C. and Hemler, M. E. (2009) Tetraspanin12 regulates ADAM10-dependent cleavage of amyloid precursor protein. FASEB J. 23, 3674-3681
47. Gutiérrez-López, M. D., Gilsanz, A., Yáñez- Mó, M., Ovalle, S., Lafuente, E. M., Domínguez, C., Monk, P. N., González-Alvaro, I.,Sánchez-Madrid, F. and Cabañas, C. (2011) The sheddase activity of ADAM17/TACE is regulated by the tetraspanin CD9. Cell. Mol. Life Sci. 68, 3275-3292
48. Arduise, C., Abache, T., Li, L., Billard, M., Chabanon, A., Ludwig, A., Mauduit, P., Boucheix, C., Rubinstein, E. and Le Naour, F. (2008) Tetraspanins regulate ADAM10-mediated cleavage of TNF-alpha and epidermal growth factor. J. Immunol. 181, 7002-7013
49. Yáñez-Mó, M., Gutiérrez-López, M. D. and Cabañas, C. (2011) Functional interplay between tetraspanins and proteases. Cell. Mol. Life Sci. 68, 3323-3335
50. Kuhn, S., Koch, M., Nübel, T., Ladwein, M., Antolovic, D., Klingbeil, P., Hildebrand, D., Moldenhauer, G., Langbein, L., Franke, W. W. et al. (2007) A complex of EpCAM, claudin-7, CD44 variant isoforms, and tetraspanins promotes colorectal cancer progression. Mol. Cancer Res. 5, 553-567 (Pubitemid 46985046)
51. Marhaba, R., Klingbeil, P., Nuebel, T., Nazarenko, I., Buechler, M. W. and Zoeller, M. (2008) CD44 and EpCAM: cancer-initiating cell markers. Curr. Mol. Med. 8, 784-804
52. Rupp, A.-K., Rupp, C., Keller, S., Brase, J. C., Ehehalt, R., Fogel, M., Moldenhauer, G., Marmé, F., Sültmann, H. and Altevogt, P. (2011) Loss of EpCAM expression in breast cancer derived serum exosomes: role of proteolytic cleavage. Gynecol. Oncol. 122, 437-446
53. Stoeck, A., Keller, S., Riedle, S., Sanderson, M. P., Runz, S., Le Naour, F., Gutwein, P., Ludwig, A., Rubinstein, E. and Altevogt, P. (2006) A role for exosomes in the constitutive and stimulus-induced ectodomain cleavage of L1 and CD44. Biochem. J. 393, 609-618 (Pubitemid 43163801)